ZETIA is an inhibitor of intestinal cholesterol (and related phytosterol) absorption indicated as an adjunct to diet to: Reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in patients with primary hyperlipidemia, alone or in combination with an HMG-CoA reductase inhibitor (statin).
MSD INTL GMBH is innovator of EZETIMIBE tablet 10MG. GLENMARK, MYLAN, SANDOZ, TEVA and WATSON are ANDA company approved by FDA.
No comments:
Post a Comment